Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ahmet Aydin

Concepts (135)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Penile Neoplasms
7
2025
45
3.720
 Why?
Urinary Bladder Neoplasms
7
2022
166
2.860
 Why?
Carcinoma, Squamous Cell
5
2021
331
1.830
 Why?
Carcinoma, Transitional Cell
3
2022
54
1.450
 Why?
Prostatic Neoplasms
3
2020
398
1.430
 Why?
Kidney Neoplasms
5
2021
181
1.420
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
86
1.340
 Why?
Carcinoma, Renal Cell
4
2021
112
0.940
 Why?
Immunotherapy
6
2021
251
0.820
 Why?
Pheochromocytoma
1
2023
35
0.810
 Why?
Adrenal Gland Neoplasms
1
2023
49
0.800
 Why?
Urothelium
1
2021
19
0.680
 Why?
BCG Vaccine
2
2020
16
0.670
 Why?
Neoadjuvant Therapy
5
2022
124
0.660
 Why?
Indocyanine Green
1
2020
29
0.660
 Why?
Cancer Vaccines
1
2021
78
0.640
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.640
 Why?
CD8-Positive T-Lymphocytes
1
2021
140
0.640
 Why?
Adjuvants, Immunologic
1
2020
51
0.620
 Why?
Male
24
2025
26882
0.610
 Why?
Anesthesia, Local
1
2019
18
0.600
 Why?
Tumor Suppressor Proteins
2
2021
127
0.600
 Why?
Edetic Acid
1
2019
13
0.600
 Why?
Immunotherapy, Adoptive
1
2021
156
0.600
 Why?
Patient Readmission
1
2021
249
0.600
 Why?
Testicular Neoplasms
4
2021
46
0.600
 Why?
Ureteral Neoplasms
1
2019
11
0.590
 Why?
Prostate-Specific Antigen
1
2019
41
0.590
 Why?
Papillomavirus Infections
1
2021
170
0.590
 Why?
Oligopeptides
1
2019
94
0.560
 Why?
Neoplasm Recurrence, Local
4
2021
639
0.540
 Why?
Humans
30
2025
52459
0.530
 Why?
Cystectomy
3
2022
52
0.520
 Why?
Arteriovenous Fistula
1
2016
27
0.490
 Why?
Neoplasms, Germ Cell and Embryonal
3
2021
20
0.440
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
1020
0.430
 Why?
Retrospective Studies
9
2022
6695
0.410
 Why?
Middle Aged
11
2021
13136
0.400
 Why?
Lymphatic Metastasis
4
2021
210
0.390
 Why?
Aged
10
2021
10243
0.380
 Why?
Neoplasm Grading
4
2020
127
0.370
 Why?
Neoplasm Invasiveness
3
2022
278
0.360
 Why?
Tumor Microenvironment
3
2021
257
0.330
 Why?
Female
13
2023
28286
0.310
 Why?
Lymph Nodes
2
2021
253
0.290
 Why?
Treatment Outcome
7
2022
5508
0.260
 Why?
Prognosis
3
2020
2100
0.230
 Why?
Social Stigma
1
2025
50
0.230
 Why?
Neoplasm Metastasis
3
2021
235
0.220
 Why?
Postoperative Complications
3
2021
1066
0.210
 Why?
Quality of Life
2
2020
893
0.210
 Why?
Early Detection of Cancer
1
2025
185
0.210
 Why?
Adrenalectomy
1
2023
33
0.210
 Why?
Adrenal Glands
1
2023
38
0.210
 Why?
Adult
8
2023
14212
0.200
 Why?
Public Health
1
2025
226
0.200
 Why?
Neoplasm Staging
3
2021
768
0.190
 Why?
Deoxycytidine
1
2022
24
0.190
 Why?
Aged, 80 and over
2
2021
3450
0.190
 Why?
Retroperitoneal Space
2
2021
25
0.190
 Why?
Muscles
1
2022
108
0.180
 Why?
Cohort Studies
3
2021
1579
0.180
 Why?
Mycobacterium bovis
1
2021
11
0.170
 Why?
Antigens, Differentiation, Myelomonocytic
1
2021
38
0.170
 Why?
Aftercare
1
2021
67
0.170
 Why?
T-Lymphocytes
2
2020
318
0.170
 Why?
Lymph Node Excision
2
2021
133
0.170
 Why?
Teratoma
1
2021
23
0.170
 Why?
Interleukin-2
1
2021
69
0.170
 Why?
Reference Standards
1
2020
52
0.170
 Why?
Tomography, Emission-Computed
1
2020
53
0.170
 Why?
Fluorouracil
1
2020
56
0.160
 Why?
Cisplatin
1
2022
282
0.160
 Why?
Lymphocyte Activation
1
2021
161
0.160
 Why?
Recurrence
2
2019
680
0.160
 Why?
Carcinoma in Situ
1
2020
72
0.160
 Why?
Antigens, CD
1
2021
213
0.160
 Why?
Sentinel Lymph Node Biopsy
1
2020
119
0.160
 Why?
Survival Rate
2
2019
944
0.150
 Why?
Gallium Isotopes
1
2019
2
0.150
 Why?
Gallium Radioisotopes
1
2019
9
0.150
 Why?
Patient Discharge
1
2021
320
0.150
 Why?
Kidney Pelvis
1
2019
16
0.150
 Why?
Disease-Free Survival
1
2020
461
0.150
 Why?
Genomics
1
2020
266
0.140
 Why?
Feasibility Studies
1
2020
404
0.140
 Why?
Papillomavirus Vaccines
1
2019
69
0.140
 Why?
Urologic Neoplasms
1
2018
12
0.140
 Why?
Ureteral Obstruction
1
2019
62
0.140
 Why?
Carcinoma, Papillary
1
2018
49
0.140
 Why?
Antineoplastic Agents
3
2020
1215
0.130
 Why?
Genetic Predisposition to Disease
1
2020
525
0.130
 Why?
Cells, Cultured
1
2021
1583
0.130
 Why?
Biopsy
1
2019
595
0.130
 Why?
Cell Proliferation
1
2021
1013
0.130
 Why?
Gene Expression Regulation, Neoplastic
1
2020
853
0.120
 Why?
Renal Artery
1
2016
32
0.120
 Why?
Nephrectomy
1
2016
81
0.120
 Why?
Time Factors
2
2020
2987
0.120
 Why?
Urinary Tract Infections
1
2015
56
0.110
 Why?
Prospective Studies
1
2020
2436
0.110
 Why?
Laparoscopy
1
2016
180
0.110
 Why?
Kidney Failure, Chronic
1
2015
205
0.100
 Why?
Kidney Transplantation
1
2015
199
0.100
 Why?
Risk Factors
1
2019
3972
0.080
 Why?
Chemotherapy, Adjuvant
2
2020
122
0.080
 Why?
Kaplan-Meier Estimate
2
2021
485
0.080
 Why?
Follow-Up Studies
3
2020
2294
0.070
 Why?
Survival Analysis
2
2021
656
0.070
 Why?
T-Lymphocyte Subsets
1
2021
40
0.040
 Why?
Immune System
1
2021
42
0.040
 Why?
Administration, Topical
1
2020
62
0.040
 Why?
Forkhead Transcription Factors
1
2021
120
0.040
 Why?
Urinary Bladder
1
2020
101
0.040
 Why?
Patient Selection
1
2020
269
0.040
 Why?
Treatment Failure
1
2019
117
0.040
 Why?
Macrophages
1
2021
357
0.030
 Why?
Socioeconomic Factors
1
2020
609
0.030
 Why?
Health Facilities
1
2017
39
0.030
 Why?
Oncolytic Virotherapy
1
2017
19
0.030
 Why?
Combined Modality Therapy
1
2018
641
0.030
 Why?
Adolescent
2
2019
6714
0.030
 Why?
Turkey
1
2015
17
0.030
 Why?
Mutation
1
2021
1331
0.030
 Why?
Clinical Trials as Topic
1
2017
461
0.030
 Why?
Child
2
2019
7195
0.030
 Why?
Graft Survival
1
2015
157
0.030
 Why?
Cytokines
1
2017
622
0.030
 Why?
Registries
1
2017
639
0.030
 Why?
Antibodies, Monoclonal
1
2017
475
0.030
 Why?
Mice
1
2020
5899
0.020
 Why?
Child, Preschool
1
2019
4046
0.020
 Why?
Young Adult
1
2018
4349
0.020
 Why?
United States
1
2017
5215
0.020
 Why?
Animals
1
2020
13485
0.010
 Why?
Aydin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (135) concept(s)
_
Co-Authors Expand Description
See all (16) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department